Protagonist Therapeutics (PTGX) Stock Highlights

41.49 | +4.93%

2024-12-21 03:09:11

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment.

Statistics

Range Today

38.91 41.68

Volume Today 2.36M

Range 1 Year

20.71 48.89

Volume 1 Year 185.39M

Range 3 Year

6.91 48.89

Volume 3 Year 699.05M

Range 10 Year

4.47 50.54

Volume 10 Year 1.19B

Highlights

Market Capitalization 2.8B (mid)

Floating Shares 44.2M

Current Price 41.49

Price To Earnings 18.51

Price To Revenue 7.09

Price To Book 5.17

Earnings Per Share 2.64

Payout Ratio 0%

Performance

Latest +4.93%

1 Month +8.36%

3 Months -9.82%

6 Months +27.86%

1 Year +91.82%

3 Years +38.58%

5 Years +480.28%

10 Years +245.75%

Benchmarks

Market Capitalization

92 / 368

Gross Profits

80 / 278

Total Revenue

297 / 300

Total Rank

347 / 368

Free Cashflow

249 / 352

Performance 5 years

13 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.